Innobiochips gathers talented and seasoned managers and partners that steer the company’s growth and ensure stable strategic development.
Management
Stéphane DUTHOIT, 55, has managed biotech companies for 26 years. He is a DVM with an MBA and turned around successfully 5 companies.
Vianney SOUPLET, 37, Co-founder, is focusing on Business development. PhD in Biology, trained in management of innovation prior to creating Innobiochips.
Christophe OLIVIER, 44, Co-founder, is running the technical development part. He has a PhD in Chemistry, published several papers and patents on biochips technology.
Strategic board
François-René LETOURNEUR, is CEO of Finovam, and an experienced venture capital investor and manager with board experience in accelerated growth situations. M&A experience in deal structuring, negociation and closing. He has an engineer's Degree and an MBA.
Claude GRENIER, Business development at Genes Diffusion, Canadian, Claude is well- known in the agro industry. He managed PIC in Europe.
Eric HALIOUA, Advisor, Eric has a DEA in molecular biology and pharmacology and a MBA. He has been principal at the management consulting company Arthur D. Little prior and co-founder of Myosix and Murigenetics. He has been CEO of Promethera Biosciences (Belgium) and is seating in several biotech companies’ boards.
Denis HENRARD, Advisor, Denis has a BS in chemistry and biochemistry, a PhD in molecular biology from the University of Illinois at Chicago. He has worked at AbboU and Ortho Clinical Diagnostics in the US and focuses now on start-ups. He was the CEO of InOvo and chairs the board of Venomtech in the UK.
Ownership
- Founders: 50,34%
- Private Investors: 4,56%
- Financial Investors: 37,73 %
- Industrials: 7,37%